Clinical Trials Logo

Visual Fields Hemianopsia clinical trials

View clinical trials related to Visual Fields Hemianopsia.

Filter by:
  • None
  • Page 1

NCT ID: NCT06266949 Not yet recruiting - Pituitary Tumor Clinical Trials

Perimetry Based on Eye-movements in Patients With (Supra)Sellar Tumors

Start date: August 1, 2024
Phase:
Study type: Observational

The purpose of this study is to assess wether the SONDA visual field test is suitable for patients with a supra sellar tumour.

NCT ID: NCT05525949 Completed - Clinical trials for Hemianopsia, Homonymous

Visual Perceptual Learning Based Digital Therapeutics for Visual Field Defect After Stroke

Start date: October 19, 2022
Phase: N/A
Study type: Interventional

This study evaluates the efficacy of visual perceptual learning for the treatment of visual field defect caused by brain disease. Half of participants will receive visual perceptual training using the VIVID Brain. The other half will not receive any training because there is no standard treatment for visual field defect caused by brain disease.

NCT ID: NCT05085210 Recruiting - Stroke Clinical Trials

Improving Visual Field Deficits With Noninvasive Brain Stimulation

Start date: January 25, 2022
Phase: N/A
Study type: Interventional

This is a randomized, pilot interventional study in participants with visual field deficit (VFD) caused by cortical lesion. Damage to the primary visual cortex (V1) causes a contra-lesional, homonymous loss of conscious vision termed hemianopsia, the loss of one half of the visual field. The goal of this project is to elaborate and refine a rehabilitation protocol for VFD participants. It is hypothesized that visual restoration training using moving stimuli coupled with noninvasive current stimulation on the visual cortex will promote and speed up recovery of visual abilities within the blind field in VFD participants. Moreover, it is expected that visual recovery positively correlates with reduction of the blind field, as measured with traditional visual perimetry: the Humphrey visual field test. Finally, although results will vary among participants depending on the extension and severity of the cortical lesion, it is expected that a bigger increase in neural response to moving stimuli in the blind visual field in cortical motion area, for those participants who will show the largest behavioral improvement after training. The overarching goals for the study are as follows: Group 1 will test the basic effects of transcranial random noise stimulation (tRNS) coupled with visual training in stroke cohorts, including (i) both chronic and subacute VFD stroke participant, and (ii) longitudinal testing up to 6 months post-treatment. Group 2 will examine the effects of tRNS alone, without visual training, also including chronic and subacute VFD stroke participants and longitudinal testing.

NCT ID: NCT04798924 Recruiting - Stroke, Ischemic Clinical Trials

Visual Rehabilitation After Occipital Stroke

Start date: July 19, 2021
Phase: N/A
Study type: Interventional

This research aims to examine changes in plastic potential of the visual system with time from stroke affecting primary visual cortex. We will measure structural and mechanistic aspects of progressive degeneration along the early visual pathways, correlating them with changes in visual performance, and in responsiveness to visual restoration training. This project will advance both scientific knowledge, as well as technical capability and clinical practices for restoring vision and quality of life for people suffering from cortical blindness.

NCT ID: NCT04102605 Completed - Clinical trials for Hemianopsia, Homonymous

Visual Perceptual Learning for the Treatment of Visual Field Defect

VIVID2
Start date: October 17, 2019
Phase: N/A
Study type: Interventional

This study evaluates the efficacy of visual perceptual learning for the treatment of visual field defect caused by brain damage. Half of participants will receive visual perceptual training using the Nunap Vision, while the other half will receive sham training using the Nunap Vision-C.

NCT ID: NCT04021160 Completed - Stroke, Ischemic Clinical Trials

Repetitive Transcranial Magnetic Stimulation for Post-Stroke Visual Field Defects

Start date: June 1, 2018
Phase: N/A
Study type: Interventional

Visual field defects (VFD) usually do not show improvement beyond 12 weeks from onset. Plasticity occurs in areas of residual vision (ARV) at the visual field which are the functional counterpart of partially damaged brain regions at the areas around brain lesion. Few treatment options are currently available for post-stroke VFD. In this pilot study, the effect of repetitive transcranial magnetic stimulation (rTMS) applied to these areas on VFD in patients with cortical infarction will be studied. Patients will be divided into two groups; an active group which will receive active stimulation and a sham group which will receive placebo stimulation through a sham coil.